(thirdQuint)Medication-related Osteonecrosis of the Jaw (MRONJ) Registry.

 Approximately 500 patients diagnosed with medication-related osteonecrosis of the jaw will be enrolled in the study.

 Patients will undergo standard (routine) of care treatment, either conservative or surgical or both, and followed up during one year after the initiation of the treatment.

 Treatment outcome (development of the condition), pain and complications will be collected and documented over the duration of the registry.

.

 Medication-related Osteonecrosis of the Jaw (MRONJ) Registry@highlight

Approximately 500 patients will be included in this patient registry.

 Data collection includes demographics, clinical data of underlying disease and use of bisphosphonates, denosumab and antiangiogenic drugs , degree and extension of osteonecrosis, osteonecrosis-specific treatment, outcomes and complications within 1 year after treatment.

